Loading...
Effect of Glycemic Control on Chylomicron Metabolism and Correlation between Postprandial Metabolism of Plasma Glucose and Chylomicron in Patients with Type 2 Diabetes Treated with Basal-bolus Insulin Therapy with or without Vildagliptin
Aim: Glucagon-like peptide-1 can reduce both postprandial plasma glucose (PG) and chylomicron (CM) levels in patients with type 2 diabetes. However, there have been no reports regarding the relationship between the postprandial metabolism of PG and CM. Methods: Patients with type 2 diabetes who were...
Na minha lista:
| Udgivet i: | J Atheroscler Thromb |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Japan Atherosclerosis Society
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5305676/ https://ncbi.nlm.nih.gov/pubmed/27397060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.32409 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|